Modalis Therapeutics Corporation
4883.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥5 | ¥4 | ¥10 | ¥18 |
| - Cash | ¥4 | ¥2 | ¥3 | ¥5 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥1 | ¥2 | ¥7 | ¥13 |
| Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| % Growth | – | -100% | 3,581.8% | – |
| Gross Profit | ¥0 | -¥0 | -¥0 | ¥0 |
| % Margin | – | – | -205.4% | 100% |
| EBITDA | -¥2 | -¥2 | -¥3 | -¥1 |
| % Margin | – | – | -6,378.7% | -60,686.1% |
| Net Income | -¥1 | -¥2 | -¥3 | -¥1 |
| % Margin | – | – | -6,673.4% | -67,177.8% |
| EPS Diluted | -28.57 | -77.24 | -92.85 | -25.7 |
| % Growth | 63% | 16.8% | -261.3% | – |
| Operating Cash Flow | -¥1 | -¥2 | -¥2 | -¥1 |
| Capital Expenditures | -¥0 | -¥0 | -¥0 | -¥0 |
| Free Cash Flow | -¥1 | -¥2 | -¥2 | -¥1 |